<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01343680</url>
  </required_header>
  <id_info>
    <org_study_id>ACH23736</org_study_id>
    <nct_id>NCT01343680</nct_id>
  </id_info>
  <brief_title>Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients</brief_title>
  <official_title>A Randomized Controlled Crossover Trial of Two Different Central Venous Catheter Flushing Schemes in Pediatric Hematology and Oncology Patients in Alberta, Canada</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alberta Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stollery Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Alberta Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether flushing Central Venous Catheters (CVCs)
      with Normal saline once per week is not inferior to flushing with 10U/ml heparin 3 times per
      week, in preventing CVC occlusions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tunneled central venous catheters (CVCs) are now used routinely in pediatric hematology and
      oncology patients. Flushing with heparin solution is routinely recommended to prevent
      occlusion of long term CVCs, although the concentration of heparin used, and frequency of its
      use varies between centres. Once weekly Normal saline is also used successfully in some
      pediatric enters. There is little evidence to support one method over the other.

      The investigators have designed a randomised crossover trial to directly compare once weekly
      Normal saline flushing with 3 times per week 10U/ml heparin flushing, to determine whether
      Normal saline is not inferior to heparin.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Poor patient accrual
  </why_stopped>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occlusion rate</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complication rate</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Childhood Cancer</condition>
  <condition>Aplastic Anemia</condition>
  <condition>Metabolic Disorders</condition>
  <arm_group>
    <arm_group_label>10U/l heparin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>normal saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Heparin</intervention_name>
    <description>5ml 10 units/ml IV heparin 3 times per week</description>
    <arm_group_label>10U/l heparin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>10ml normal saline IV weekly</description>
    <arm_group_label>normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Diagnosis of any malignant or nonmalignant disease that requires a single lumen
             Broviac or double lumen Hickman-type CVC for the purpose of chemotherapy, blood
             product support or hematopoietic stem cell transplantation.

          -  CVC is planned to remain in situ for 6 months from study entry

        Exclusion Criteria:

          -  Thrombophilia (e.g. Factor V Leiden mutation, antiphospholipid syndrome) or previous
             thrombosis requiring anticoagulation (e.g. enoxaparin, unfractionated heparin)

          -  Bleeding disorder (e.g. von Willebrand's disease, hemophilia)

          -  Previous CVC that was removed due to any complication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin A Campbell, MBBS FRACP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alberta Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alberta Children's Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T3B6A8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stollery Children's Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2011</study_first_submitted>
  <study_first_submitted_qc>April 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2011</study_first_posted>
  <last_update_submitted>May 29, 2012</last_update_submitted>
  <last_update_submitted_qc>May 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alberta Children's Hospital</investigator_affiliation>
    <investigator_full_name>Martin Campbell</investigator_full_name>
    <investigator_title>Paediatric Oncologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Aplastic</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Flushing</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

